ACE and Nephropathy: The higher prescription rate of ACE inhibitors among men can potentially be explained not only by the higher CVD comorbidity, but also by the higher prevalence of nephropathy in men than in women and the protective effect of ACE inhibitors towards progression of nephropathy [23].